Defining the next level for InovaSecond story in a three-part series November 17, 2017Vol.43 No.43By Paul Goldberg
CMS plan to slash $1.6 billion from 340B program will reduce discounts on cancer drugs November 10, 2017Vol.43 No.42By Matthew Bin Han Ong
Conversation with The Cancer Letter Trump’s plans for Inova reach across the Washington Beltway, through Virginia—and beyond November 10, 2017Vol.43 No.42By Paul Goldberg
Drugs & Targets FDA approves Kite’s CAR-T cell therapy; another win for NCI’s intramural program November 07, 2017Vol.40 No.09By Matthew Bin Han Ong
Pfizer, Astellas report positive results from trial of Xtandi in non-metastatic castration-resistant disease November 07, 2017Vol.40 No.09
Cleveland Clinic study: timing of melanoma diagnosis, treatment critical to survival November 07, 2017Vol.40 No.09
Local radiation provides comparable control of brain metastases compared to surgery November 07, 2017Vol.40 No.09
